Clinical Trial Update: Effects of Multimodal Cognitive Enhancement Therapy (MCET) for Ealy Dementia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Multimodal Cognitive Enhancement Therapy (MCET) for mild cognitive impairment and mild dementia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment
• Dementia

Snippet

Sponsor: Ki Woong Kim | Conditions: Mild Cognitive Impairment, Dementia, Mild | Phase 3 | Status: COMPLETED